Skip to main content
Log in

Current issues in the economics of depression management

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

In this paper, we present a systematic review of the literature on current issues in the economics of depression management, focusing on studies within three distinct areas of interest: 1) t he clinical and economic outcomes o alternative patterns of antidepressant use; 2) the impact of depression and antidepressant therapy on the costs of general medical-care services; and 3) t he effects of depression and associated benefits of antidepressant therapy on worker productivity. Our review suggests that 1) patterns of antidepressant use are important predictors of symptom improvement, relapse/recurrence, and costs of care, and that use patterns vary according to the antidepressant received as initial therapy; 2) patients with depression have higher costs of general medical-care services compared with their nondepressed peers, and that treatment of depression may reduce these costs; and 3)depression can result in productivity losses via increased rates of absenteeism and short-term disability as well as via impaired on-the-job performance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Katon W, von Korff M, Lin E, et al.: Adequacy and duration of antidepressant treatment in primary care. Med Care 1992, 0:67–76.

    Article  CAS  Google Scholar 

  2. Hirschfeld RM, Keller MB, Panico S, et al.: The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 1997, 277:333–340.

    Article  PubMed  CAS  Google Scholar 

  3. Greenberg PE, Stiglin LE, Finkelstein SN, et al.: The economic bur den of depression in 1990. J Clin Psychiatry 1993, 54:405–418.

    PubMed  CAS  Google Scholar 

  4. Conner TM, Crismon ML, Still DJ: A critical review of selected pharmacoeconomic analyses of antidepressant therapy. Ann Pharmacother 1999, 33:364–372.

    Article  PubMed  CAS  Google Scholar 

  5. Gabbard GO: The cost effectiveness of treating depression. Psychiatr Ann 1998, 28:98–101.

    Google Scholar 

  6. Hylan TR, Buesching DP, Tollefson GD: Health economic evaluations of antidepressants: a review. Depress Anxiety 1998 7:53 64.

    Article  PubMed  Google Scholar 

  7. Wilde MI, Benfield P: Fluoxetine a pharmacoeconomic review of its use in depression. Pharmacoeconomics 1998, 13(5Pt 1):543–561.

    Article  PubMed  CAS  Google Scholar 

  8. Franco K, Tamburino M, Cambell N, et al.: The added costs of depression to medical care. Pharmacoeconomics 1995, 7:284–291.

    PubMed  CAS  Google Scholar 

  9. Saklad SR: Pharmacoeconomic issues in the treatment of depression. Pharmacotherapy 1995, 15(6 Pt 2):76S-83S.

    PubMed  CAS  Google Scholar 

  10. World Health Organization Mental Health Collaborating Centers: Pharmacotherapy of depressive disorders: WHO consensus statement. J Affect Disord 1989, 17:197–198.

    Article  Google Scholar 

  11. Depression in Primary Care: volume 2. Treatment of major depression clinical practice guidelines, number 5. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy Research; April, 1993. AHCPR publication no. 93–0551.

  12. American Psychiatric Association: Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993, 150(Suppl):1–26.

    Google Scholar 

  13. Katzelnick DJ, Kobak KA, Jefferson JW, et al.: Prescribing patterns of antidepressant medications for depression in a HMO. Formulary 1996, 31:374–388.

    Google Scholar 

  14. Thompson D, Buesching D, Gregor KJ, et al.: Patterns of antidepressant use and their relation to costs of care. Am J Man Care 1996, 2:1239–1246.

    Google Scholar 

  15. Crown WH, Hylan TR, Meneades L: Antidepressant selection and use and healthcare expenditures an empirical approach. Pharmacoeconomics 1998, 13:435–448.

    Article  PubMed  CAS  Google Scholar 

  16. Melfi CA, Chawla AJ, Croghan TW, et al.: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998, 55 1128–1132. This study examines the effect of antidepressant use pattern on relapse and recurrence of depression in a sample of more than 4,000 Medicaid beneficiaries. Early discontinuation of therapy was associated with a 77% increase in the likelihood of relapse and recurrence.

    Article  PubMed  CAS  Google Scholar 

  17. Revicki DA, Simon GE, Chan K, et al.: Depression, healthrelated quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment. J Fam Pract 1998, 47:446–452.

    PubMed  CAS  Google Scholar 

  18. Hylan TR, Meneades L, Crown WH, et al.: SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study. J Affect Disord 1999, 52:111–119.

    Article  PubMed  CAS  Google Scholar 

  19. Hylan TR, Crown WH, Meneades L, et al.: SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting a multivariate analysis. Med Care 1999, 37:AS36-AS44.

    Article  PubMed  CAS  Google Scholar 

  20. McCombs JS, Nichol MB, Stimmel GL: The role of SSRI antidepressants for treating depressed patients in the California medicaid (Medi-Cal) program. Val Health 1999, 2:269–280. This study examined the effects of adequate versus inadequate course of antidepressant therapy on 12-month health-care costs among more than 1600 California Medicaid recipients. An adequate course of therapy was an important determinant of health-care costs, which was reflected in reduced costs for therapies associated with better patterns of use.

    Article  CAS  Google Scholar 

  21. Katon W, Kleinman A, Rosen G: Depression and somatization: a review. Am J Med 1982, 72:127–135.

    Article  PubMed  CAS  Google Scholar 

  22. Simon GE, Katzelnick DJ: Depression, use of medical services and cost-offset effects. J Psychosom Res 1997, 42:333–344.

    Article  PubMed  CAS  Google Scholar 

  23. Henk HJ, Katzelnick DJ, Kobak KA, et al.: Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psychiatry 1996, 53:899–904.

    PubMed  CAS  Google Scholar 

  24. Katzelnick DJ, Kobak KA, Greist JH, et al.: Effect of primary care treatment of depression on service use by patients with hig medical expenditures. Psychiatric Services 1997, 48:59–64.

    PubMed  CAS  Google Scholar 

  25. Unutzer J, Patrick DL, Simon G, et al.: Depressive symptoms and the cost of health services in HMO patients aged 65 years and older a 4-year prospective study. JAMA 1997, 277 1618–1623.

    Article  PubMed  CAS  Google Scholar 

  26. Croghan TW, Obenchain RL, Crown WE: What does treatment of depression really cost?. Health Aff 1998, 17:198–208.

    Article  CAS  Google Scholar 

  27. Thompson D, Hylan TR, McMullen W, et al.: Predictors of a medical-offset effect among patients receiving antidepressant therapy. Am J Psychiatry 1998, 155:824–827.

    PubMed  CAS  Google Scholar 

  28. Finkelstein SN, Berndt ER, Greenber PE, et al.: Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Psychopharmacol Bull 1996, 32:33–40.

    PubMed  CAS  Google Scholar 

  29. Kessler RC, Frank RG: The impact of psychiatric disorders on work loss days. Psychol Med 1997, 27:861–873.

    Article  PubMed  CAS  Google Scholar 

  30. Berndt ER, Finkelstein SN, Greenber PE, et al.: Workplace performance effects from chronic depression and its treatment. J Health Econ 1998, 17:511–535.

    Article  PubMed  CAS  Google Scholar 

  31. Claxton AJ, Chawla AJ, Kennedy S: Absenteeism among employees treated for depression. Journal of Occupational and Environmental Medicine 1999, 41:605–611.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, D., Richardson, E. Current issues in the economics of depression management. Curr Psychiatry Rep 1, 125–134 (1999). https://doi.org/10.1007/s11920-999-0021-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-999-0021-1

Keywords

Navigation